Summary
Normolipidaemic insulin-dependent diabetic (IDDM) patients are characterized by an increase in the smaller VLDL particles, considered to be the most atherogenic. Since blood glucose control is one of the main regulators of lipid metabolism in diabetic patients, it could influence the shift in the distribution of VLDL subfractions towards smaller particles. To evaluate this possibility, VLDL subfractions, post-heparin lipoprotein lipase and hepatic lipase activities have been evaluated in male IDDM patients with either unsatisfactory blood glucose control (group 1, HbA1c>8%, n=18) or good blood glucose control (group 2, HbA1c<8%, n=16) and in 16 normoglycaemic individuals. The three groups were comparable for sex, age, body mass index, and plasma lipid levels. Three VLDL subfractions (large, Svedberg flotation unit (Sf) 175–400; intermediate, Sf 100–175; small, Sf 20–100) were separated by density gradient ultracentrifugation and analysed for cholesterol, triglyceride, and phospholipid levels. When compared to control subjects both groups of IDDM patients showed a clear shift in VLDL subfraction distribution with a significant increase in the proportion of small VLDL (group 1; 49±2%; p<0.005; group 2: 51±3%, p<0.01; control subjects 40±2%) (mean ± SEM) in relation to total VLDL. By contrast, the absolute lipid concentration of small VLDL was higher only in group 1, compared to control subjects (35±4 vs 27±3 mg/dl, p=0.05). Post-heparin hepatic lipase activity was significantly reduced in both IDDM groups (group 1: 254±19 mU/ ml, p<0.05; group 2: 202±19 mU/ml, p<0.005; control subjects 317±31 mU/ml). In conclusion, normolipidaemic IDDM patients show an increase in the smallest VLDL, whatever their degree of blood glucose control. However, this abnormality may be clinically relevant only in patients with unsatisfactory blood glucose control, since absolute lipid concentration of these potentially atherogenic particles is only increased in this group.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- IDDM:
-
Insulin-dependent diabetes mellitus
- VLDL:
-
very low density lipoprotein
- LPL:
-
lipoprotein lipase
- HL:
-
hepatic lipase
References
Krolewski AS, Kosinski EJ, Warram JH et al. (1987) Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 59: 750–755
Taskinen MR (1992) Quantitative and qualitative abnormalities in diabetes mellitus. Diabetes 41 (Suppl 2): 12–17
Manzato E, Zambon A, Zambon S et al. (1993) Lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients. Acta Diabetol 30: 11–16
Winocour PH, Durrington PN, Bhatnagar D, Ishola M, Arrol S, Mackness M (1992) Abnormalities of VLDL, IDL, and LDL characterize insulin-dependent diabetes mellitus. Arterioscler Thromb 12: 920–928
Bagdade JD, Helve E, Taskinen MR (1991) Effects of continuous insulin infusion therapy on lipoprotein surface and core lipid composition in insulin-dependent diabetes mellitus. Metabolism 40: 445–449
Bagdade JB, Subbaiah PV (1989) Abnormal high density lipoprotein composition in insulin-dependent diabetic women. J Lab Clin Med 113: 235–240
Austin MA (1991) Plasma triglyceride and coronary heart disease. Arterioscler Thromb 11: 2–14
Zambon A, Austin MA, Brown BG, Hokanson JE, Brunzell JD (1993) Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler Thromb 13: 147–153
Patti L, Romano G, Di Marino L et al. (1993) Abnormal distribution of VLDL subfractions in type 1 (insulin-dependent) diabetic patients: could plasma lipase activities play a role? Diabetologia 36: 155–160
Ostlund RE, Samenkovich CF, Schechtman KB (1989) Quantitative relationship between plasma lipids and glycohemoglobin in type 1 diabetes. Diabetes Care 12: 332–336
Rivellese A, Riccardi G, Romano G et al. (1988) Presence of very low density lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients: effects of blood glucose optimisation. Diabetologia 31: 884–888
Howard BV (1987) Lipoprotein metabolism in diabetes mellitus. J Lipid Res 28: 613–628
WHO Expert Committee on Diabetes Mellitus (1980) Second Report. Tech Rep Ser 646, World Health Organization, Geneva
Hatch FT, Lees RS (1968) Practical methods for plasma lipoprotein analysis. In: Paoletti R, Kritchevsky D (eds) Advances in lipid research. Vol 6. Academic Press, London, pp 1–68
Koster GM (1976) Enzymatic determination of cholesterol in high density lipoprotein fractions prepared by polyanion precipitation. Clin Chem 22: 695–698
Carlson K (1973) Lipoprotein fractionation. J Clin Pathol [Suppl 5] 26: 32–37
Lindgren FT, Jensen LC, Hatch FT (1972) The isolation and quantitative analysis of serum lipoproteins. In: Nelsen GJ (ed) Blood lipids and lipoproteins: quantitation, composition and metabolism. Wiley-Interscience, New York, pp 181–274
Redgrave TR, Carlson LA (1979) Changes in plasma very low density and low density lipoprotein content, composition, and size after a fatty meal in normo- and hypertriglyceridemic men. J Lipid Res 20: 217–229
Nilsson-Ehle P, Ekman R (1977) Rapid, simple and specific assay for lipoprotein lipase and hepatic lipase. Artery 3: 194–209
Staehler F, Gruber W, Stinshoff K, Roeschlau P (1977) Eine praktischgerechte enzymatische Cholesterin-Bestimmung. Med Lab 30: 29–30
Siedel J, Schlumberger H, Klose S, Ziegenhorm J, Wahlefeld AW (1981) Improved reagent for enzymatic determination of serum cholesterol. J Clin-Chem Clin Biochem 19: 838–839
Wahlefeld AW (1974) Triglyceride determination after enzymatic hydrolysis. In: Bergmeyer HU (ed) Methods of enzymatic analysis. 2nd edn, Vol 4. Verlag Chemie, Weinheim Academic Press, New York, London, pp 1831–1974
Takaiama M, Itoh S, Nagasaki T, Tanimizu I (1979) A new enzymatic method for determination of serum choline containing phospholipids. Clin Chim Acta 79: 93–98
Grafnetter D (1977) World Health Organization (WHO) coordinated quality control in the lipid laboratory. Giorn Arterioscl 2: 113–128
Davis H, McDonald JM, Jarrett J (1978) A high performance liquid chromatography method in haemoglobin A1c. Diabetes 27: 102–107
Snedecor GW, Cochran WG (1980) Statistical methods. 7th edn. The Iowa State University Press, Ames
Ruotolo G, Parlavecchia M, Taskinen MR et al. (1994) Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Diabetes Care 17: 6–12
Georgolopoulos A, Sauder CD (1994) Intraperitoneal insulin delivery decreases the levels of chylomicron remnants in patients with IDDM. Diabetes Care 17: 1295–1299
Baynes C, Henderson AD, Richmond W, Johnston DG, Elkeles RS (1992) The response of hepatic lipase and serum lipoproteins to acute hyperinsulinemia in type 2 diabetes. Eur J Clin Invest 22: 341–346
Pietri AO, Dunn FL, Raskin P, Grundy SM (1983) The effect of continuous subcutaneous insulin infusion on very-low-density lipoprotein triglyceride metabolism in type 1 diabetes mellitus. Diabetes 32: 75–81
Taskinen MR, Packard CJ, Shepherd J (1990) Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM. Diabetes 39: 1017–1027
Bagdade JD, Dunn FL (1992) Effects of insulin treatment on lipoprotein composition and function in patients with IDDM Diabetes [Suppl 2] 41: 107–110
Mahley RW, Innerarity TL, Brown MS, Ho YK, Goldstein JL (1980) Cholesteryl ester synthesis in macrophages: stimulation by Β-very low density lipoproteins from cholesterol-fed animals of several species. J Lipid Res 21: 970–980
Tatami R, Mabuchi H, Ueda K et al. (1981) Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease. Circulation 64: 1174–1184
James RW, Pometta D (1990) Differences in lipoprotein subfraction composition and distribution between type 1 diabetic men and control subjects. Diabetes 39: 1158–1164
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Patti, L., Di Marino, L., Maffettone, A. et al. Very low density lipoprotein subfraction abnormalities in IDDM patients: any effect of blood glucose control?. Diabetologia 38, 1419–1424 (1995). https://doi.org/10.1007/BF00400602
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400602